Johnson & Johnson vs VICI Properties Inc — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while VICI Properties Inc trades at $22.88 (market cap $25.09B). The key difference: Johnson & Johnson is far larger — about 24.6× VICI Properties Inc's market cap, and VICI Properties Inc pays the higher dividend (8.07%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and VICI Properties Inc for 43 Days on average.
| JNJ | VICI | |
|---|---|---|
Market Cap | $618.09B | $25.09B |
Volume | 6,050,983 | 17,066,337 |
Sector | Health | Real Estate |
52-Week High | $278.43 | $31.42 |
52-Week Low | $186.00 | $22.53 |
Typical Hold Time | 129 Days | 43 Days |
Enterprise Value | $646.37B | $42.65B |
Dividend Yield | 2.09% | 8.07% |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
VICI Properties trades at $22.81, showing modest daily gains of 0.75% amid bearish technical signals. The REIT maintains strong fundamentals with a 67.5% net income margin and attractive valuation at 8.83 P/E ratio. Recent earnings show mixed results with Q1 2026 beating expectations but Q2 missing. The company continues dividend payments with a $0.46 distribution scheduled for October 2026, supported by robust cash flow generation of $2.51 billion from operations in 2025.
Wall Street maintains strong bullish sentiment with 75% buy ratings and $28.90 consensus price target representing 27% upside potential. Key risks include tenant concentration with major operators undergoing ownership changes and rising interest rate environment pressure. The current valuation discount to analyst targets presents opportunity, though technical weakness and earnings volatility warrant cautious optimism for income-focused investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →